靶点针对疾病信息25(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
B-lymphocyte surface antigen B4 (CD19)
INDICATI
Approved Diffuse large B-cell lymphoma [ICD-11: 2A81]
INDICATI
Approved Malignant haematopoietic neoplasm [ICD-11: 2B33]
INDICATI
Approved Mature B-cell leukaemia [ICD-11: 2A82]
INDICATI
Approved Mature B-cell lymphoma [ICD-11: 2A85]
INDICATI
Approved Nervous system paraneoplastic/autoimmune disorder [ICD-11: 8E4A]
INDICATI
Approved Precursor B-lymphoblastic neoplasm [ICD-11: 2A70]
INDICATI
Phase 2/3 B-cell lymphoma [ICD-11: 2A86]
INDICATI
Phase 2/3 Diabetes mellitus [ICD-11: 5A10]
INDICATI
Phase 2 Encephalopathy [ICD-11: 8E47]
INDICATI
Phase 2 Leukaemia [ICD-11: 2A60-2B33]
INDICATI
Phase 2 Lupus erythematosus [ICD-11: 4A40]
INDICATI
Phase 2 Multiple myeloma [ICD-11: 2A83]
INDICATI
Phase 2 Sjogren syndrome [ICD-11: 4A43]